These injections are particularly beneficial for those with a body mass index (BMI) of 27 or higher
[3] Other common adverse effects reported during the clinical trials include back pain, upper respiratory tract infections, melanocyte naevus, decreased appetite, migraine, dizziness, weakness, fatigue, lethargy, sleepiness, hot flashes, abdominal pain, diarrhea, vomiting, flushing, development of warts, spots, and freckles, and itchy skin (between 1% and 10% of people)
Drugmakers Taking Legal Action Against Physicians, Telehealth Companies It should also be noted that the drugmakers may also take legal action against physicians and businesses marketing or prescribing compounded versions of their drug
if not, they could cause serious health issues
Never take semaglutide and tirzepatide at the same time